Patent · US Active

Negative allosteric modulators of MGLUR5 for use in the treatment of mature brain damages

US11033545B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

Sinntaxis AB · SE

Inventors

Tadeusz Wieloch · Lund, SE
Carin Sjölund · Malmö, SE
Kerstin Beirup · Lund, SE
Karsten Ruscher · Lund, SE
Roger Olsson · Bunkeflostrand, SE

Key dates

Filing date	Mar 30, 2016
Grant date	Jun 15, 2021
Priority date	—
Expiry date	Mar 30, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to the use of negative allosteric modulators (NAMs) of the metabotropic glutamate receptor 5 (mGluR5) in the treatment of a mature brain damage, such as damage after stroke.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.